Breaking News Instant updates and real-time market news.

UWMC

UWM Holdings

$9.12 /

+1.525 (+20.08%)

14:05
03/02/21
03/02
14:05
03/02/21
14:05

UWM Holdings Corp call volume above normal and directionally bullish

Bullish option flow detected in UWM Holdings Corp with 139,033 calls trading, 5x expected, and implied vol increasing over 23 points to 106.53%. Mar-21 10 calls and Mar-21 9 calls are the most active options, with total volume in those strikes near 54,900 contracts. The Put/Call Ratio is 0.07. Earnings are expected on May 5th.

UWMC UWM Holdings
$9.12 /

+1.525 (+20.08%)

02/23/21 Credit Suisse
UWM Holdings initiated with an Outperform at Credit Suisse
02/17/21 Goldman Sachs
UWM Holdings initiated with a Neutral at Goldman Sachs
02/16/21 Deutsche Bank
UWM Holdings initiated with a Buy at Deutsche Bank

TODAY'S FREE FLY STORIES

Hot Stocks
Talend: 'Go-shop' period expires related to Thoma Bravo acquistion » 08:37
04/12/21
04/12
08:37
04/12/21
08:37
TLND

Talend

$64.71 /

+0.27 (+0.42%)

Talend announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TLND Talend
$64.71 /

+0.27 (+0.42%)

TLND Talend
$64.71 /

+0.27 (+0.42%)

03/11/21
Fly Intel: Top five analyst downgrades
03/11/21 Needham
Talend downgraded to Hold from Buy at Needham
03/10/21 Craig-Hallum
Talend go-shop 'could spark interest,' says Craig-Hallum
03/10/21 William Blair
Talend downgraded to Market Perform from Outperform at William Blair
TLND Talend
$64.71 /

+0.27 (+0.42%)

TLND Talend
$64.71 /

+0.27 (+0.42%)

Hot Stocks
Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37
04/12/21
04/12
08:37
04/12/21
08:37
GNPX

Genprex

$4.46 /

-0.415 (-8.51%)

Genprex announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GNPX Genprex
$4.46 /

-0.415 (-8.51%)

GNPX Genprex
$4.46 /

-0.415 (-8.51%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
Hot Stocks
Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37
04/12/21
04/12
08:37
04/12/21
08:37
GNPX

Genprex

$4.46 /

-0.415 (-8.51%)

Genprex announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNPX Genprex
$4.46 /

-0.415 (-8.51%)

GNPX Genprex
$4.46 /

-0.415 (-8.51%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
Recommendations
Alibaba named a Research Tactical Idea at Morgan Stanley » 08:37
04/12/21
04/12
08:37
04/12/21
08:37
BABA

Alibaba

$223.35 /

-4.9 (-2.15%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

07:37 Today Raymond James
Alibaba price target lowered to $330 from $350 at Raymond James
06:41 Today Mizuho
Alibaba antitrust ruling 'removes overhang,' says Mizuho
06:37 Today Citi
Alibaba fine could help lift 'overhang' on shares, says Citi
06:36 Today KeyBanc
Alibaba price target lowered to $305 from $315 at KeyBanc
BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

Hot Stocks
Rayonier Advanced Materials to sell lumber, newsprint assets to GreenFirst » 08:37
04/12/21
04/12
08:37
04/12/21
08:37
RYAM

Rayonier Advanced Materials

$9.66 /

-0.05 (-0.51%)

Rayonier Advanced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RYAM Rayonier Advanced Materials
$9.66 /

-0.05 (-0.51%)

RYAM Rayonier Advanced Materials
$9.66 /

-0.05 (-0.51%)

10/20/20
Fly Intel: Top five analyst upgrades
10/20/20 RBC Capital
Rayonier Advanced Materials upgraded to Outperform at RBC Capital
10/20/20 RBC Capital
Rayonier Advanced upgraded to Outperform from Sector Perform at RBC Capital
06/19/20
Fly Intel: Top five analyst upgrades
RYAM Rayonier Advanced Materials
$9.66 /

-0.05 (-0.51%)

RYAM Rayonier Advanced Materials
$9.66 /

-0.05 (-0.51%)

Hot Stocks
Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37
04/12/21
04/12
08:37
04/12/21
08:37
GNPX

Genprex

$4.46 /

-0.415 (-8.51%)

Genprex announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNPX Genprex
$4.46 /

-0.415 (-8.51%)

GNPX Genprex
$4.46 /

-0.415 (-8.51%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
Hot Stocks
TC Energy announces issuance of renewable energy RFI » 08:37
04/12/21
04/12
08:37
04/12/21
08:37
TRP

TC Energy

$46.80 /

-0.24 (-0.51%)

TC Energy Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRP TC Energy
$46.80 /

-0.24 (-0.51%)

TRP TC Energy
$46.80 /

-0.24 (-0.51%)

03/19/21 Evercore ISI
TC Energy resumed with an In Line at Evercore ISI
03/01/21 Wells Fargo
TC PipeLines downgraded to Equal Weight from Overweight at Wells Fargo
02/19/21 TD Securities
TC Energy price target lowered to C$73 from C$75 at TD Securities
02/19/21 CIBC
TC Energy price target raised to C$70 from C$69 at CIBC
TRP TC Energy
$46.80 /

-0.24 (-0.51%)

TRP TC Energy
$46.80 /

-0.24 (-0.51%)

Hot Stocks
Medigus says Polyrizon commences pre-clinical study of bio-gel » 08:35
04/12/21
04/12
08:35
04/12/21
08:35
MDGS

Medigus

$2.03 /

-0.035 (-1.70%)

Medigus announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDGS Medigus
$2.03 /

-0.035 (-1.70%)

  • 11
    Jan
  • 02
    Dec
  • 20
    May
Hot Stocks
Microsoft to acquire Nuance for $56.00 per share in cash, or $19.7B » 08:35
04/12/21
04/12
08:35
04/12/21
08:35
MSFT

Microsoft

$255.73 /

+2.37 (+0.94%)

, NUAN

Nuance

$45.59 /

+0.38 (+0.84%)

Microsoft (MSFT) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

NUAN Nuance
$45.59 /

+0.38 (+0.84%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

08:30 Today Stifel
Microsoft a 'logical buyer' of Nuance, says Stifel
07:36 Today B. Riley
Nuance possible takeout positive for peer LivePerson, says B. Riley
07:29 Today Wedbush
Nuance deal would be 'trophy' for Microsoft, says Wedbush
07:11 Today BMO Capital
Microsoft price target raised to $280 from $270 at BMO Capital
NUAN Nuance
$45.59 /

+0.38 (+0.84%)

08:30 Today Stifel
Microsoft a 'logical buyer' of Nuance, says Stifel
07:36 Today B. Riley
Nuance possible takeout positive for peer LivePerson, says B. Riley
07:29 Today Wedbush
Nuance deal would be 'trophy' for Microsoft, says Wedbush
03/10/21 Wedbush
Nuance added to Best Ideas List at Wedbush
MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

NUAN Nuance
$45.59 /

+0.38 (+0.84%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

NUAN Nuance
$45.59 /

+0.38 (+0.84%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

NUAN Nuance
$45.59 /

+0.38 (+0.84%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

NUAN Nuance
$45.59 /

+0.38 (+0.84%)

General news
Oil Action: WTI crude » 08:35
04/12/21
04/12
08:35
04/12/21
08:35
$ECON

Economic Data

/

+

Oil Action: WTI crude is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Hot Stocks
    Artelo Biosciences doses first patient in CAReS study with ART27.13 » 08:34
    04/12/21
    04/12
    08:34
    04/12/21
    08:34
    ARTL

    Artelo Biosciences

    $1.53 /

    -0.055 (-3.47%)

    Artelo Biosciences…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    ARTL Artelo Biosciences
    $1.53 /

    -0.055 (-3.47%)

    ARTL Artelo Biosciences
    $1.53 /

    -0.055 (-3.47%)

    02/12/21 Ladenburg
    Artelo Biosciences initiated with a Buy at Ladenburg
    01/07/21 Maxim
    Artelo Biosciences upgraded to Buy from Hold at Maxim
    01/07/21 Maxim
    Artelo Biosciences upgraded to Buy from Hold at Maxim
    05/13/20 Maxim
    Artelo Biosciences downgraded to Hold from Buy at Maxim
    ARTL Artelo Biosciences
    $1.53 /

    -0.055 (-3.47%)

    • 09
      Oct
    Recommendations
    Chicken Soup for the Soul price target raised to $48 from $35 at Craig-Hallum » 08:34
    04/12/21
    04/12
    08:34
    04/12/21
    08:34
    CSSE

    Chicken Soup for the Soul

    $32.50 /

    +4.54 (+16.24%)

    Craig-Hallum analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    CSSE Chicken Soup for the Soul
    $32.50 /

    +4.54 (+16.24%)

    CSSE Chicken Soup for the Soul
    $32.50 /

    +4.54 (+16.24%)

    08:23 Today Northland
    Chicken Soup for the Soul price target raised to $40 from $30 at Northland
    04/09/21 Alliance Global Partners
    Alliance Global raises Chicken Soup for the Soul price target to $48 after deal
    04/01/21 DA Davidson
    Chicken Soup for the Soul price target raised to $34 from $28 at DA Davidson
    04/01/21 Craig-Hallum
    Chicken Soup for the Soul price target raised to $35 from $30 at Craig-Hallum
    Hot Stocks
    Infinity Energy completes purchase of production, acresin Central Kansas Uplift » 08:33
    04/12/21
    04/12
    08:33
    04/12/21
    08:33
    IFNY

    Infinity Energy Resources

    /

    +

    Infinity Energy Resources…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Recommendations
    B. Riley calls Agenus the next Seagen, reiterates $8 target » 08:33
    04/12/21
    04/12
    08:33
    04/12/21
    08:33
    AGEN

    Agenus

    $2.78 /

    -0.01 (-0.36%)

    , MRK

    Merck

    $76.33 /

    +0.855 (+1.13%)

    , BMY

    Bristol-Myers

    $62.61 /

    +0.695 (+1.12%)

    , AZN

    AstraZeneca

    $49.95 /

    +0.465 (+0.94%)

    , RHHBY

    Roche

    $41.93 /

    +0.53 (+1.28%)

    , SGEN

    Seagen

    $142.81 /

    -1.68 (-1.16%)

    B. Riley analyst Mayank…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    AGEN Agenus
    $2.78 /

    -0.01 (-0.36%)

    MRK Merck
    $76.33 /

    +0.855 (+1.13%)

    BMY Bristol-Myers
    $62.61 /

    +0.695 (+1.12%)

    AZN AstraZeneca
    $49.95 /

    +0.465 (+0.94%)

    RHHBY Roche
    $41.93 /

    +0.53 (+1.28%)

    SGEN Seagen
    $142.81 /

    -1.68 (-1.16%)

    AGEN Agenus
    $2.78 /

    -0.01 (-0.36%)

    09/22/20 B. Riley FBR
    B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
    09/18/20 Jefferies
    Agenus price target raised to $8 from $5 at Jefferies
    MRK Merck
    $76.33 /

    +0.855 (+1.13%)

    04/08/21 Alliance Global Partners
    Alliance Global Partners sees Fast Track for Immutep efti as meaningful positive
    04/08/21 H.C. Wainwright
    Alkermes collaboration not as big as investors wanted, says H.C. Wainwright
    04/07/21 Mizuho
    Mizuho sees Alkermes, Merck collaboration as important next step for nemvaleukin
    04/06/21 RBC Capital
    Merck transferred with a Sector Perform at RBC Capital
    BMY Bristol-Myers
    $62.61 /

    +0.695 (+1.12%)

    03/08/21 BofA
    Gartner added to US 1 List, Bristol-Myers removed at BofA
    02/12/21 Morgan Stanley
    Amgen court decision may have readthrough for Gilead, says Morgan Stanley
    02/02/21 BTIG
    Prothena upgraded to Buy at BTIG on birtamimab 'revival'
    01/20/21 William Blair
    Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
    AZN AstraZeneca
    $49.95 /

    +0.465 (+0.94%)

    07:18 Today Argus
    AstraZeneca downgraded to Hold from Buy at Argus
    07:09 Today Argus
    AstraZeneca downgraded to Hold from Buy at Argus
    04/07/21 Citi
    FibroGen update creates only 'bad optic' for AstraZeneca, says Citi
    03/26/21 Piper Sandler
    AstraZeneca plan 'opens the door' for Altimmune interest, says Piper Sandler
    RHHBY Roche
    $41.93 /

    +0.53 (+1.28%)

    03/29/21 RBC Capital
    PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
    03/25/21 Wedbush
    iTeos Therapeutics price target raised to $52 from $46 at Wedbush
    03/23/21 Truist
    Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
    03/23/21 BMO Capital
    Ionis Pharmaceuticals price target lowered to $76 from $90 at BMO Capital
    SGEN Seagen
    $142.81 /

    -1.68 (-1.16%)

    03/30/21 Credit Suisse
    Seagen initiated with a Neutral at Credit Suisse
    03/30/21 Credit Suisse
    Seagen initiated with a Neutral at Credit Suisse
    02/16/21 RBC Capital
    Seagen price target lowered to $169 from $186 at RBC Capital
    02/12/21 Barclays
    Seagen price target lowered to $168 from $177 at Barclays
    AGEN Agenus
    $2.78 /

    -0.01 (-0.36%)

    MRK Merck
    $76.33 /

    +0.855 (+1.13%)

    BMY Bristol-Myers
    $62.61 /

    +0.695 (+1.12%)

    AZN AstraZeneca
    $49.95 /

    +0.465 (+0.94%)

    RHHBY Roche
    $41.93 /

    +0.53 (+1.28%)

    SGEN Seagen
    $142.81 /

    -1.68 (-1.16%)

    MRK Merck
    $76.33 /

    +0.855 (+1.13%)

    BMY Bristol-Myers
    $62.61 /

    +0.695 (+1.12%)

    AZN AstraZeneca
    $49.95 /

    +0.465 (+0.94%)

    RHHBY Roche
    $41.93 /

    +0.53 (+1.28%)

    MRK Merck
    $76.33 /

    +0.855 (+1.13%)

    BMY Bristol-Myers
    $62.61 /

    +0.695 (+1.12%)

    AZN AstraZeneca
    $49.95 /

    +0.465 (+0.94%)

    RHHBY Roche
    $41.93 /

    +0.53 (+1.28%)

    SGEN Seagen
    $142.81 /

    -1.68 (-1.16%)

    MRK Merck
    $76.33 /

    +0.855 (+1.13%)

    BMY Bristol-Myers
    $62.61 /

    +0.695 (+1.12%)

    AZN AstraZeneca
    $49.95 /

    +0.465 (+0.94%)

    Hot Stocks
    Homology Medicines announces promotion of Tim Kelly to COO » 08:32
    04/12/21
    04/12
    08:32
    04/12/21
    08:32
    FIXX

    Homology Medicines

    $7.30 /

    -0.17 (-2.28%)

    Homology Medicines…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    03/01/21 Stifel
    Homology Medicines initiated with a Hold at Stifel
    03/01/21 Oppenheimer
    Homology Medicines loses potential source of upside, says Oppenheimer
    12/14/20 H.C. Wainwright
    Homology Medicines transferred with Buy, $30 target at H.C. Wainwright
    11/08/20 Oppenheimer
    Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer
    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    • 07
      Apr
    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    Hot Stocks
    Homology Medicines announces promotion of Tim Kelly to COO » 08:32
    04/12/21
    04/12
    08:32
    04/12/21
    08:32
    FIXX

    Homology Medicines

    $7.30 /

    -0.17 (-2.28%)

    Homology Medicines…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    03/01/21 Stifel
    Homology Medicines initiated with a Hold at Stifel
    03/01/21 Oppenheimer
    Homology Medicines loses potential source of upside, says Oppenheimer
    12/14/20 H.C. Wainwright
    Homology Medicines transferred with Buy, $30 target at H.C. Wainwright
    11/08/20 Oppenheimer
    Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer
    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    • 07
      Apr
    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    Hot Stocks
    Microsoft to acquire Nuance for $56.00 per share in cash  08:32
    04/12/21
    04/12
    08:32
    04/12/21
    08:32
    MSFT

    Microsoft

    $255.73 /

    +2.37 (+0.94%)

    , NUAN

    Nuance

    $45.59 /

    +0.38 (+0.84%)

     
    ShowHide Related Items >><<
    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    08:30 Today Stifel
    Microsoft a 'logical buyer' of Nuance, says Stifel
    07:36 Today B. Riley
    Nuance possible takeout positive for peer LivePerson, says B. Riley
    07:29 Today Wedbush
    Nuance deal would be 'trophy' for Microsoft, says Wedbush
    07:11 Today BMO Capital
    Microsoft price target raised to $280 from $270 at BMO Capital
    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    08:30 Today Stifel
    Microsoft a 'logical buyer' of Nuance, says Stifel
    07:36 Today B. Riley
    Nuance possible takeout positive for peer LivePerson, says B. Riley
    07:29 Today Wedbush
    Nuance deal would be 'trophy' for Microsoft, says Wedbush
    03/10/21 Wedbush
    Nuance added to Best Ideas List at Wedbush
    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    Recommendations
    Microsoft a 'logical buyer' of Nuance, says Stifel » 08:30
    04/12/21
    04/12
    08:30
    04/12/21
    08:30
    NUAN

    Nuance

    $45.59 /

    +0.38 (+0.84%)

    , MSFT

    Microsoft

    $255.73 /

    +2.37 (+0.94%)

    After Bloomberg reported…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    07:36 Today B. Riley
    Nuance possible takeout positive for peer LivePerson, says B. Riley
    07:29 Today Wedbush
    Nuance deal would be 'trophy' for Microsoft, says Wedbush
    03/10/21 Wedbush
    Nuance added to Best Ideas List at Wedbush
    03/08/21 Morgan Stanley
    Software industry rating raised to Attractive from In-Line at Morgan Stanley
    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    07:36 Today B. Riley
    Nuance possible takeout positive for peer LivePerson, says B. Riley
    07:29 Today Wedbush
    Nuance deal would be 'trophy' for Microsoft, says Wedbush
    07:11 Today BMO Capital
    Microsoft price target raised to $280 from $270 at BMO Capital
    04/09/21 BTIG
    Okta upgraded to Buy from Neutral at BTIG
    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    Options
    Five new option listings on April 12th » 08:30
    04/12/21
    04/12
    08:30
    04/12/21
    08:30
    ACVA

    ACV Auctions

    $31.29 /

    -0.31 (-0.98%)

    , DSEY

    Diversey

    $14.79 /

    -0.12 (-0.80%)

    , RICE

    Rice Acquisition

    $17.25 /

    +1.94 (+12.67%)

    , TDUP

    thredUP

    $18.44 /

    +0.07 (+0.38%)

    , ULCC

    Frontier Group

    $21.35 /

    +0.08 (+0.38%)

    New option listings for…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    RICE Rice Acquisition
    $17.25 /

    +1.94 (+12.67%)

    ACVA ACV Auctions
    $31.29 /

    -0.31 (-0.98%)

    03/29/21 Northcoast
    ACV Auctions initiated with a Neutral at Northcoast
    DSEY Diversey
    $14.79 /

    -0.12 (-0.80%)

    RICE Rice Acquisition
    $17.25 /

    +1.94 (+12.67%)

    TDUP thredUP
    $18.44 /

    +0.07 (+0.38%)

    ULCC Frontier Group
    $21.35 /

    +0.08 (+0.38%)

    • 01
      Apr
    • 26
      Mar
    • 25
      Mar
    • 24
      Mar
    ACVA ACV Auctions
    $31.29 /

    -0.31 (-0.98%)

    DSEY Diversey
    $14.79 /

    -0.12 (-0.80%)

    RICE Rice Acquisition
    $17.25 /

    +1.94 (+12.67%)

    TDUP thredUP
    $18.44 /

    +0.07 (+0.38%)

    ULCC Frontier Group
    $21.35 /

    +0.08 (+0.38%)

    Conference/Events
    Oncolytics to hold a Key Opinion Leader conference call » 08:28
    04/12/21
    04/12
    08:28
    04/12/21
    08:28
    ONCY

    Oncolytics

    $3.99 /

    -0.61 (-13.26%)

    Management holds a Key…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ONCY Oncolytics
    $3.99 /

    -0.61 (-13.26%)

    ONCY Oncolytics
    $3.99 /

    -0.61 (-13.26%)

    02/17/21 H.C. Wainwright
    Oncolytics initiated with a Buy at H.C. Wainwright
    05/11/20 RBC Capital
    Oncolytics price target lowered to C$6 from C$9 at RBC Capital
    ONCY Oncolytics
    $3.99 /

    -0.61 (-13.26%)

    Periodicals
    Study shows Covid variant may evade protection from Pfizer vaccine, Reuters says » 08:27
    04/12/21
    04/12
    08:27
    04/12/21
    08:27
    PFE

    Pfizer

    $36.60 /

    +0.64 (+1.78%)

    , BNTX

    BioNTech

    $122.15 /

    +7.68 (+6.71%)

    The coronavirus variant…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PFE Pfizer
    $36.60 /

    +0.64 (+1.78%)

    BNTX BioNTech
    $122.15 /

    +7.68 (+6.71%)

    PFE Pfizer
    $36.60 /

    +0.64 (+1.78%)

    04/09/21
    Pfizer to host conference call
    04/06/21 RBC Capital
    Pfizer transferred with a Sector Perform at RBC Capital
    03/17/21 Mizuho
    AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
    02/23/21 B. Riley Securities
    B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
    BNTX BioNTech
    $122.15 /

    +7.68 (+6.71%)

    02/23/21 B. Riley Securities
    B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
    02/01/21 SVB Leerink
    Moderna price target raised to $80 from $69 at SVB Leerink
    01/29/21 Piper Sandler
    Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
    01/14/21 Morgan Stanley
    80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
    PFE Pfizer
    $36.60 /

    +0.64 (+1.78%)

    • 23
      Jul
    PFE Pfizer
    $36.60 /

    +0.64 (+1.78%)

    BNTX BioNTech
    $122.15 /

    +7.68 (+6.71%)

    PFE Pfizer
    $36.60 /

    +0.64 (+1.78%)

    BNTX BioNTech
    $122.15 /

    +7.68 (+6.71%)

    PFE Pfizer
    $36.60 /

    +0.64 (+1.78%)

    BNTX BioNTech
    $122.15 /

    +7.68 (+6.71%)

    Hot Stocks
    Kronos Advanced Technologies acquires 600M Dogecoin Cash » 08:25
    04/12/21
    04/12
    08:25
    04/12/21
    08:25
    KNOS

    Kronos Advanced Technologies

    /

    +

    KRONOS ADVANCED…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    Technical Analysis
    DJ Transportation Average: Pivot points » 08:25
    04/12/21
    04/12
    08:25
    04/12/21
    08:25
    $DJT

    DJ Transportation Average

    /

    +

    The following are the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    $DJT DJ Transportation Average
    /

    +

    Technical Analysis
    DJ Utility Average: Pivot points » 08:25
    04/12/21
    04/12
    08:25
    04/12/21
    08:25
    $DJU

    DJ Utility Average

    /

    +

    The following are the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    $DJU DJ Utility Average
    /

    +

    Conference/Events
    Incyte to hold a conference call » 08:25
    04/12/21
    04/12
    08:25
    04/12/21
    08:25
    INCY

    Incyte

    $79.97 /

    -0.91 (-1.13%)

    Management discusses…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    INCY Incyte
    $79.97 /

    -0.91 (-1.13%)

    INCY Incyte
    $79.97 /

    -0.91 (-1.13%)

    02/10/21 SVB Leerink
    Incyte downgraded to Market Perform from Outperform at SVB Leerink
    01/07/21 Truist
    Incyte initiated with a Buy at Truist
    01/07/21 Truist
    Incyte initiated with a Buy at Truist
    01/04/21 Guggenheim
    Incyte upgraded to Buy from Neutral at Guggenheim
    INCY Incyte
    $79.97 /

    -0.91 (-1.13%)

    INCY Incyte
    $79.97 /

    -0.91 (-1.13%)

    INCY Incyte
    $79.97 /

    -0.91 (-1.13%)

    INCY Incyte
    $79.97 /

    -0.91 (-1.13%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.